Overall rank by patents
#24,814
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
According to USPTO PatentsView, Mitegen ranks #24,814 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 11 technology areas.
USPTO PatentsView assignee plate
Corpus R24814 · US Corporation #24,814 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Meike Technology (beijing) Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Ingevity South Carol… · near
53 score
Mitegen · this assignee
53 score
Panasonic Connect No… · near
53 score
University Of Puerto… · near
53 score
Waldemar LINK & KG · near
53 score
3D Lighting Innovati… · lowest
7 score
What this shows Mitegen's Innovation Score is 52.9/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Mitegen, Llc is a focused PatentsView assignee: 11 CPC subclasses with 63.6% of grants classified under G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2018. By volume, Mitegen sits between Meike Technology (beijing) Ltd. and Microvascular Tissues, Inc..
Mitegen, Llc shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Meike Technology (Beijing) Ltd.
11 patents
Merge Labs Inc.
11 patents
Meridian Innovation Pte Limited
11 patents
Metis Design Corporation
11 patents
MiZ Company Limited
11 patents
Michellia Inc.
11 patents
Micro Macro Assets, LLC
11 patents
MicroVascular Tissues, Inc.
11 patents
MiTeGen, LLC
11 patents
What this shows Mitegen holds 11 patents at rank #24,807, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,807 in granted patent volume.
Other assignees with the most granted patents in Mitegen's primary technology class.
Two PlainPatent-derived peer sets for Mitegen, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (53 here).
Mitegen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
53 Top 10% higher than 90% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2022 | 1 | 9.1% |
| 2023 | 2 | 18.2% |
| 2024 | 2 | 18.2% |
| 2025partial year | 4 | 36.4% |
Top 11 of 11 technology areas
Overall rank by patents
#24,814
of 50,000 tracked assignees
52.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.